Posttransplant primary cutaneous CD30(Ki-1)-positive anaplastic large T-cell lymphoma. A case report [5]

British Journal of Dermatology

Volumn 152, Issue 5, 2005, Pages 1068-1070

  De Nisi, M C ^a   D'Amuri, A ^a   Lalinga, A V ^a   Occhini, R ^a   Biagioli, M ^a   Miracco, C ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ANAPLASTIC LARGE T CELL LYMPHOMA; CASE REPORT; DRUG DOSE REDUCTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LETTER; LYMPHOPROLIFERATIVE DISEASE; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA;

DNA-BINDING PROTEINS; HEART TRANSPLANTATION; HUMANS; INTERFERON REGULATORY FACTORS; LYMPHOMA, LARGE-CELL, KI-1; MALE; MIDDLE AGED; NEOPLASM PROTEINS; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 18944376563     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06535.x     Document Type: Letter

References (9)

1. Harris NL, Swerdlow SH, Frizzera G, Knowles DM. Post-transplant lymphoproliferative disorders. In: WHO Classification of Tumours. Tumours of Haematopoietic and Lymphoid Tissues (Jaffe ES, Harris NL, Stein H, Vardiman JN, eds). Lyon: IARC Press, 2001; 264-71.
2. Coyne JD, Banerjee SS, Bromley M et al. Post-transplant T-cell lymphoproliferative disorder/T-cell lymphoma: a reporc of three cases of T-anaplascic large-cell lymphoma wich cutaneous presentation and a review of the literature. Histopathology 2004; 44:387-93.
3. Seçkin D, Demirhan B, Ouz Güleçc T et al. Posttransplantation primary cutaneous CD30 (Ki-1)-positive large-cell lymphoma. J Am Acad Dermatol 2001; 45 (Suppl. 6):S197-9.
4. Cooper SM, Turner GD, Hollowood K et al. Primary cutaneous large cell CD30+ lymphoma in a renal transplant recipient. Br J Dermatol 2003; 149:426-8.
5. Stein H, Foss HD, Durkop H. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000; 96:3681-95.
6. Bekkenk MW, Geelen FA, van Voorst Vader PC el el. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the longterm follow-up dala of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 93:3653-61.
7. Gaidano G, Carbone A. MUM1: a step ahead toward the understanding of lymphoma histogenesis. Leukemia 2000; 14:563-6.
8. Chang CC, Lorek J, Sabath DE et al. Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. Blood 2002; 100:4671-5. Epub 2002 Aug 01.
9. Colomo L, López-Guillermo A, Perales M et al. Clinical impacl of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 2003; 101:78-84. Epub 2002 Aug 08.